Ekso Bionics Holdings, Inc.
EKSO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $184 | $520 | $231 | $485 |
| - Cash | $6 | $9 | $21 | $40 |
| + Debt | $6 | $7 | $8 | $2 |
| Enterprise Value | $184 | $519 | $218 | $446 |
| Revenue | $18 | $18 | $13 | $11 |
| % Growth | -1.9% | 41.6% | 14.8% | – |
| Gross Profit | $10 | $9 | $6 | $7 |
| % Margin | 53.1% | 49.7% | 48.1% | 60% |
| EBITDA | -$9 | -$13 | -$14 | -$9 |
| % Margin | -52.7% | -72.2% | -108.7% | -80.8% |
| Net Income | -$11 | -$15 | -$15 | -$10 |
| % Margin | -63.2% | -83.1% | -116.8% | -86.8% |
| EPS Diluted | -0.56 | -1.1 | -1.16 | -0.88 |
| % Growth | 49.1% | 5.2% | -31.8% | – |
| Operating Cash Flow | -$10 | -$12 | -$15 | -$11 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$12 | -$15 | -$11 |